Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Yannick AllanoreDinesh KhannaVanessa SmithMartin AringerAnna-Maria Hoffmann-VoldMasataka KuwanaPeter A MerkelChristian StockSteven SambevskiChristopher P Dentonnull nullPublished in: Rheumatology (Oxford, England) (2023)
ClinicalTrials.gov (https://www.clinicaltrials.gov), NCT02597933 and NCT03313180.